Global pharmaceutical companies, and the healthcare sector, are working intensively to reduce their climate and environmental impact. How is your business affected by the ambitious environmental goals of your customers and partners? What demands are placed on, and what opportunities arise for, innovative companies?
The Atlas of Childhood Diseases (ACD) project, supported by the Erling-Persson Foundation, seeks to explore the cellular and molecular landscape of childhood diseases that have their origin in intrauterine development. By identifying previously inaccessible mechanisms behind these conditions, our goal is to utilize them to design innovative therapeutic approaches and highlight early diagnostic biomarkers, paving the way for better outcomes for children affected by these conditions.
CHRISTINE WERGELAND SØRBYE: While we were discussing how health data and AI can transform the healthcare industry in the Nordics, President Emmanuel Macron was at the AI Action Summit in Paris securing multi-billion-euro investments in France’s technological future. This is the competition we are up against. The time to act is now.
Carl Johan Sundberg is now a member of the board at Stockholm Science City Foundation. He is a Professor at the Department of Physiology and Pharmacology and Dean for Karolinska Institutet Campus North. Carl Johan's research focuses on the effects of physical activity and its role in the prevention and treatment of disease.
Astrid Berg started working as a Process Leader at the Foundation in January. Here, she talks about herself and her previous work experience. And, of course, what the best part of working in life science is!